Literature DB >> 5635341

Treatment of persistent central serous retinopathy.

R R Peabody, H C Zweng, H L Little.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5635341     DOI： 10.1001/archopht.1968.03850040168011

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  6 in total

1.  Central serous chorioretinopathy: to treat or not to treat?

Authors:  J J De Laey
Journal:  Doc Ophthalmol       Date:  1986-01-15       Impact factor: 2.379

2.  Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy.

Authors:  L Ficker; G Vafidis; A While; P Leaver
Journal:  Br J Ophthalmol       Date:  1988-11       Impact factor: 4.638

Review 3.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

4.  Type A behavior and central serous chorioretinopathy.

Authors:  L A Yannuzzi
Journal:  Trans Am Ophthalmol Soc       Date:  1986

5.  Argon laser photocoagulation in the treatment of central serous retinopathy.

Authors:  P Leaver; C Williams
Journal:  Br J Ophthalmol       Date:  1979-10       Impact factor: 4.638

6.  Visual phenomena following light coagulation in central serous retinopathy (CSR).

Authors:  B Kovács
Journal:  Doc Ophthalmol       Date:  1977-12-30       Impact factor: 2.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.